Crossref journal-article
Springer Science and Business Media LLC
Gene Therapy (297)
Bibliography

Dardalhon, V., Herpers, B., Noraz, N., Pflumio, F., Guetard, D., Leveau, C., Dubart-Kupperschmitt, A., Charneau, P., & Taylor, N. (2001). Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Therapy, 8(3), 190–198.

Authors 9
  1. V Dardalhon (first)
  2. B Herpers (additional)
  3. N Noraz (additional)
  4. F Pflumio (additional)
  5. D Guetard (additional)
  6. C Leveau (additional)
  7. A Dubart-Kupperschmitt (additional)
  8. P Charneau (additional)
  9. N Taylor (additional)
References 49 Referenced 79
  1. Plavec I et al. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS Gene Therapy 1997 4: 128–139 (10.1038/sj.gt.3300369) / Gene Therapy by I Plavec (1997)
  2. Roth T et al. Synthesis and biological activity of novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-sub-stituted benzimidazoles J Med Chem 1997 40: 4199–4207 (10.1021/jm970096g) / J Med Chem by T Roth (1997)
  3. Hwu P et al. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain J Exp Med 1993 178: 361–366 (10.1084/jem.178.1.361) / J Exp Med by P Hwu (1993)
  4. Chinen J et al. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene Hum Gene Ther 1997 8: 861–868 (10.1089/hum.1997.8.7-861) / Hum Gene Ther by J Chinen (1997)
  5. Blaese RM et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years Science 1995 270: 475–480 (10.1126/science.270.5235.475) / Science by RM Blaese (1995)
  6. Bordignon C et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients Science 1995 270: 470–475 (10.1126/science.270.5235.470) / Science by C Bordignon (1995)
  7. Kohn DB et al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates Nature Med 1998 4: 775–780 (10.1038/nm0798-775) / Nature Med by DB Kohn (1998)
  8. Mavilio F et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer Blood 1994 83: 1988–1997 (10.1182/blood.V83.7.1988.1988) / Blood by F Mavilio (1994)
  9. Bunnell BA et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes Proc Natl Acad Sci USA 1995 92: 7739–7743 (10.1073/pnas.92.17.7739) / Proc Natl Acad Sci USA by BA Bunnell (1995)
  10. Rudoll T et al. High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes Gene Therapy 1996 3: 695–705 / Gene Therapy by T Rudoll (1996)
  11. Lam JS et al. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope Hum Gene Ther 1996 7: 1415–1422 (10.1089/hum.1996.7.12-1415) / Hum Gene Ther by JS Lam (1996)
  12. Pollok KE et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments J Virol 1998 72: 4882–4892 (10.1128/JVI.72.6.4882-4892.1998) / J Virol by KE Pollok (1998)
  13. Fehse B et al. Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin Br J Haematol 1998 102: 566–574 (10.1046/j.1365-2141.1998.00785.x) / Br J Haematol by B Fehse (1998)
  14. Dardalhon V et al. Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes Hum Gene Ther 1999 10: 5–14 (10.1089/10430349950019147) / Hum Gene Ther by V Dardalhon (1999)
  15. Roe T et al. Integration of murine leukemia virus DNA depends on mitosis EMBO J 1993 12: 2099–2108 (10.1002/j.1460-2075.1993.tb05858.x) / EMBO J by T Roe (1993)
  16. Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection Mol Cell Biol 1990 10: 4239–4242 (10.1128/MCB.10.8.4239) / Mol Cell Biol by DG Miller (1990)
  17. Lewis PF, Emerman M . Passage through mitosis is required for oncoretroviruses, but not for the human immunodeficiency virus J Virol 1994 68: 510–516 (10.1128/jvi.68.1.510-516.1994) / J Virol by PF Lewis (1994)
  18. Miyoshi H et al. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector Proc Natl Acad Sci USA 1997 94: 10319–10323 (10.1073/pnas.94.19.10319) / Proc Natl Acad Sci USA by H Miyoshi (1997)
  19. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 1996 272: 263–267 (10.1126/science.272.5259.263) / Science by L Naldini (1996)
  20. Poeschla E, Corbeau P, Wong-Staal F . Development of HIV vectors for anti-HIV gene therapy Proc Natl Acad Sci USA 1996 93: 11395–11399 (10.1073/pnas.93.21.11395) / Proc Natl Acad Sci USA by E Poeschla (1996)
  21. Uchida N et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells Proc Natl Acad Sci USA 1998 95: 11939–11944 (10.1073/pnas.95.20.11939) / Proc Natl Acad Sci USA by N Uchida (1998)
  22. Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 1997 15: 871–875 (10.1038/nbt0997-871) / Nat Biotechnol by R Zufferey (1997)
  23. Reiser J et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles Proc Natl Acad Sci USA 1996 93: 15266–15271 (10.1073/pnas.93.26.15266) / Proc Natl Acad Sci USA by J Reiser (1996)
  24. Unutmaz D et al. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes J Exp Med 1999 189: 1735–1746 (10.1084/jem.189.11.1735) / J Exp Med by D Unutmaz (1999)
  25. Zack JA . The role of the cell cycle in HIV-1 infection Adv Exp Med Biol 1995 374: 27–31 (10.1007/978-1-4615-1995-9_3) / Adv Exp Med Biol by JA Zack (1995)
  26. Charneau P, Alizon M, Clavel F . A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication J Virol 1992 66: 2814–2820 (10.1128/jvi.66.5.2814-2820.1992) / J Virol by P Charneau (1992)
  27. Charneau P et al. HIV-1 reverse transcription. A termination step at the center of the genome J Mol Biol 1994 241: 651–662 (10.1006/jmbi.1994.1542) / J Mol Biol by P Charneau (1994)
  28. Zennou V et al. HIV-1 genome nuclear import is mediated by a central DNA flap Cell 2000 101: 173–185 (10.1016/S0092-8674(00)80828-4) / Cell by V Zennou (2000)
  29. Sirven A et al. The HIV-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells Blood 2000 96: 4103–4110 (10.1182/blood.V96.13.4103.h8004103_4103_4110) / Blood by A Sirven (2000)
  30. Follenzi A et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences Nat Genet 2000 25: 217–222 (10.1038/76095) / Nat Genet by A Follenzi (2000)
  31. Uckert W et al. Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype Hum Gene Ther 2000 11: 1005–1014 (10.1089/10430340050015310) / Hum Gene Ther by W Uckert (2000)
  32. Uetsuki T et al. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha J Biol Chem 1989 264: 5791–5798 (10.1016/S0021-9258(18)83619-5) / J Biol Chem by T Uetsuki (1989)
  33. Quinn ER, Lum LG, Trevor KT . T cell activation modulates retrovirus-mediated gene expression Hum Gene Ther 1998 9: 1457–1467 (10.1089/hum.1998.9.10-1457) / Hum Gene Ther by ER Quinn (1998)
  34. Agarwal M et al. Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells J Virol 1998 72: 3720–3728 (10.1128/JVI.72.5.3720-3728.1998) / J Virol by M Agarwal (1998)
  35. Douglas J et al. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors Hum Gene Ther 1999 10: 935–945 (10.1089/10430349950018337) / Hum Gene Ther by J Douglas (1999)
  36. Page KA, Landau NR, Littman DR . Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity J Virol 1990 64: 5270–5276 (10.1128/jvi.64.11.5270-5276.1990) / J Virol by KA Page (1990)
  37. Zufferey R et al. Self-inactivating lentiviral vector for safe and efficient in vivo gene delivery. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo J Virol 1998 72: 9873–9880 (10.1128/JVI.72.12.9873-9880.1998) / J Virol by R Zufferey (1998)
  38. Korin YD, Zack JA . Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells J Virol 1998 72: 3161–3168 (10.1128/JVI.72.4.3161-3168.1998) / J Virol by YD Korin (1998)
  39. Case SS et al. Stable transduction of quiescent CD34(+)CD38(−) human hematopoietic cells by HIV-1-based lentiviral vectors Proc Natl Acad Sci USA 1999 96: 2988–2993 (10.1073/pnas.96.6.2988) / Proc Natl Acad Sci USA by SS Case (1999)
  40. Wells AD, Gudmundsdottir H, Turka LA . Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response J Clin Invest 1997 100: 3173–3183 (10.1172/JCI119873) / J Clin Invest by AD Wells (1997)
  41. Riley JL et al. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis J Virol 1998 72: 8273–8280 (10.1128/JVI.72.10.8273-8280.1998) / J Virol by JL Riley (1998)
  42. Levine BL et al. CD28 ligands CD80 (B7–1) and CD86 (B7–2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro Int Immunol 1995 7: 891–904 (10.1093/intimm/7.6.891) / Int Immunol by BL Levine (1995)
  43. Costello E et al. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors Gene Therapy 2000 7: 596–604 (10.1038/sj.gt.3301135) / Gene Therapy by E Costello (2000)
  44. Kung SK, An DS, Chen IS . A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes J Virol 2000 74: 3668–3681 (10.1128/JVI.74.8.3668-3681.2000) / J Virol by SK Kung (2000)
  45. Pollok KE et al. Costimulation of transduced T lymphocytes via T cell receptor–CD3 complex and CD28 leads to increased transcription of integrated retrovirus Hum Gene Ther 1999 10: 2221–2236 (10.1089/10430349950017202) / Hum Gene Ther by KE Pollok (1999)
  46. Yee JK et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes Proc Natl Acad Sci USA 1994 91: 9564–9568 (10.1073/pnas.91.20.9564) / Proc Natl Acad Sci USA by JK Yee (1994)
  47. Dardalhon V et al. Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector Blood 2000 96: 885–893 (10.1182/blood.V96.3.885.015k22_885_893) / Blood by V Dardalhon (2000)
  48. Moritz T, Patel VP, Williams DA . Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors J Clin Invest 1994 93: 1451–1457 (10.1172/JCI117122) / J Clin Invest by T Moritz (1994)
  49. Kimizuka F et al. Production and characterization of functional domains of human fibronectin expressed in Escherichia coli J Biochem 1991 110: 284–291 (10.1093/oxfordjournals.jbchem.a123572) / J Biochem by F Kimizuka (1991)
Dates
Type When
Created 23 years ago (Sept. 4, 2002, 12:57 p.m.)
Deposited 3 years, 5 months ago (March 29, 2022, 9:26 p.m.)
Indexed 1 year ago (Aug. 8, 2024, 3:18 p.m.)
Issued 24 years, 7 months ago (Feb. 1, 2001)
Published 24 years, 7 months ago (Feb. 1, 2001)
Published Online 24 years, 4 months ago (April 6, 2001)
Published Print 24 years, 7 months ago (Feb. 1, 2001)
Funders 0

None

@article{Dardalhon_2001, title={Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap}, volume={8}, ISSN={1476-5462}, url={http://dx.doi.org/10.1038/sj.gt.3301378}, DOI={10.1038/sj.gt.3301378}, number={3}, journal={Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Dardalhon, V and Herpers, B and Noraz, N and Pflumio, F and Guetard, D and Leveau, C and Dubart-Kupperschmitt, A and Charneau, P and Taylor, N}, year={2001}, month=feb, pages={190–198} }